Meeting
2014 ASCO Quality Care Symposium
Effectiveness of cisplatin versus carboplatin-based doublet chemotherapy in elderly Medicare patients with advanced non-small cell lung cancer.
Authors
Elizabeth B. Lamont
Massachusetts General Hospital Cancer Center, Boston, MA
Elizabeth B. Lamont, Nancy Lynn Keating, Christopher G. Azzoli, Mary Beth Landrum
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Science of Quality and Cost, Value, and Policy in Quality
Track
Science of Quality,Cost, Value, and Policy in Quality
Sub Track
Studies Using Registries or Combining Large Databases
Citation
J Clin Oncol 32, 2014 (suppl 30; abstr 284)
DOI
10.1200/jco.2014.32.30_suppl.284
Abstract #
284
Poster Bd #
F25
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Low skeletal muscle area and association with toxicity and hospitalization with chemotherapy in advanced non–small cell lung cancer.
First Author: Anurag Saraf
Poster
2015 ASCO Annual Meeting
An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer.
First Author: Jianxing He
Poster
2014 ASCO Annual Meeting
Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with platinum-based doublet chemotherapy (PT-DC) in advanced non-small cell lung cancer (NSCLC).
First Author: Scott Joseph Antonia
Poster
2014 ASCO Annual Meeting
Carboplatin-based chemoradiotherapy in advanced cervical cancer: An alternative to cisplatin-based regimen?
First Author: Ana Morais Sebastião